Skin and Connective Tissue Diseases Clinical Trial
Official title:
A Phase 2a Trial Evaluating the Anti-psoriatic Effect of LEO 90100 Aerosol Foam Compared to Betesil® Medicated Plaster in the Treatment of Psoriasis Vulgaris
The purpose of this study is to evaluate the anti-psoriatic effect of LEO 90100 aerosol foam compared with Betesil® medicated plaster
The products will be applied on 6 test sites (each product on 3 test sites) once daily 6 days a week (except Sundays) for 4 weeks. The application sites for each product will be determined according to random assignment. Depending on the size of the psoriasis plaques, 2 or 4 test sites will be located within the same plaque; the treatment assignment will be done pair-wise. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04971200 -
Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo
|
Early Phase 1 | |
| Active, not recruiting |
NCT05525741 -
Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients
|
N/A | |
| Completed |
NCT02379793 -
Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects
|
Phase 1 | |
| Completed |
NCT01093911 -
Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)
|
Phase 1 | |
| Completed |
NCT00147511 -
Time To Efficacy and Onset Of Action Of Linezolid
|
Phase 4 | |
| Completed |
NCT02355639 -
A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin
|
Phase 1 | |
| Completed |
NCT01764594 -
Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus
|
Phase 1 | |
| Active, not recruiting |
NCT05185258 -
Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study
|
Phase 4 | |
| Completed |
NCT02985437 -
Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin
|
Phase 1 | |
| Not yet recruiting |
NCT06427889 -
Treatment Effects of Two Pharmaceutical Skin Care Creams for Xerotic Feet Among Persons With Diabetes
|
Phase 4 | |
| Withdrawn |
NCT03196115 -
Biomarker for Hyaline Fibromatosis Syndrome (BioHFS)
|
||
| Completed |
NCT02416258 -
A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)
|
Phase 2 |